Evidence map›Paper›PMID 38003568›Full record

ArticleInternational journal of molecular sciences2023

Improved 2,3-Butanediol Production Rate of Metabolically Engineered

Masahiko Sugimura, Taisuke Seike, Nobuyuki Okahashi, Yoshihiro Izumi, Takeshi Bamba, Jun Ishii, Fumio Matsuda

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 11 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Masahiko SugimuraDepartment of Bioinformatics Engineering, Graduate School of Information Science and Technology, Osaka University, 1-5 Yamadaoka, Suita 565-0871, Osaka, Japan.
Taisuke SeikeDepartment of Bioinformatics Engineering, Graduate School of Information Science and Technology, Osaka University, 1-5 Yamadaoka, Suita 565-0871, Osaka, Japan.ORCID 0000-0002-8738-7759
Nobuyuki OkahashiDepartment of Bioinformatics Engineering, Graduate School of Information Science and Technology, Osaka University, 1-5 Yamadaoka, Suita 565-0871, Osaka, Japan.ORCID 0000-0001-9582-355X
Yoshihiro IzumiDivision of Metabolomics/Mass Spectrometry Center, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Fukuoka, Japan.ORCID 0000-0003-4608-4652
Takeshi BambaDivision of Metabolomics/Mass Spectrometry Center, Medical Research Center for High Depth Omics, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Fukuoka, Japan.ORCID 0000-0002-7442-2738
Jun IshiiGraduate School of Science, Technology and Innovation, Kobe University, 1-1 Rokkodai, Nada, Kobe 657-8501, Hyogo, Japan.ORCID 0000-0003-2568-515X
Fumio MatsudaDepartment of Bioinformatics Engineering, Graduate School of Information Science and Technology, Osaka University, 1-5 Yamadaoka, Suita 565-0871, Osaka, Japan.
The University of Osaka · JPKyushu University · JPKobe University · JP

Funding

Japan Science and Technology Agency CREST Grant Number JPMJCR21N2Japan Society for the Promotion of Science Grants in Aid for Scientific Research (B) 22H01879
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pyruvic AcidSaccharomyces cerevisiaeButylene GlycolsEthanolFermentationMetabolic Engineering2,3-butylene glycolButylene GlycolsEthanolPyruvic Acid2,3-butanediolGibbs free energy changemetabolic engineeringmetabolome analysisRIM15Saccharomyces cerevisiae

Identifiers

PMID38003568
PMCPMC10671664
OpenAlexW4388695629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.